France· FR:62476935
EZETIMIBE/ATORVASTATINE TEVA 10 mg/10 mg, comprimé pelliculé
A medicinal product containing ézétimibe + atorvastatine calcique trihydratée, registered in France by TEVA (PAYS-BAS), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ÉZÉTIMIBE + ATORVASTATINE CALCIQUE TRIHYDRATÉE
- Manufacturer
- TEVA (PAYS-BAS)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip133400930286241plaquette(s) OPA : polyamide orienté aluminium PVC de 30 comprimé(s)EUR 10.43
- cip133400930286289plaquette(s) OPA : polyamide orienté aluminium PVC de 90 comprimé(s)EUR 30.75
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ézétimibe + atorvastatine calcique trihydratée in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAMEDO PLUSMedochemie Bohemia, spol. s r.o., Praha
- SpainATORDUO 10 MG/10 MG CAPSULAS DURASEgis Pharmaceuticals Plc.
- NetherlandsAtozet 10 mg/10 mg, filmomhulde tablettenN.V. Organon (Kloosterstraat 6)
- ItalyANCILLEGSANDOZ S.P.A.
- SwitzerlandAtorvastatin Ezetimib Zentiva
- IrelandAtozet 10 mg/10 mg film-coated tabletsPCO Manufacturing Ltd.
- PolandAtozetOrganon Polska Sp. z o.o.
- GermanyAtorimibApontis Pharma Deutschland Gmbh & Co. Kg
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Atorvacor + Ezetimib, Atozet
- Belgium · Atozet, Ezetimibe/Atorvastatin Krka
- Bulgaria · Аванор Плюс, Зетовар
- Cyprus · Amicor Plus, Atoritimb
- Czechia · Amedo Plus, Atoris Plus
- Germany · Atorimib, Atozet
- Denmark · Atozet
- Estonia · Atoritimb, Atorvastatin/Ezetimibe Teva
- Spain · Atorduo, Atorvastatina/Ezetimiba Cinfa
- Finland · Ezetimib/Atorvastatin Krka
- United Kingdom (Northern Ireland) · Atozet
- Greece · Ancilleg, Ator-Chol Plus
- Croatia · Altrexyl, Artas Plus
- Hungary · Atoris Plus, Cholezta
- Ireland · Atozet, Ezetimibe/Atorvastatin
- Iceland · Ezetimibe/Atorvastatin Stada
- Italy · Ancilleg, Athemibe
- Lithuania · Aterezim, Atorvastatin/Ezetimibe Teva
- Luxembourg · Atozet, Ezetimib/Atorvastatin Ratiopharm
- Latvia · Aterezim, Atorvastatin/Ezetimibe Teva
- Malta · Amicor Plus, Atozet
- Netherlands · Atozet, Ezeat
- Poland · Coatoris, Ezetimibe + Atorvastatin Sandoz
- Portugal · Atorduo, Atorvastatina + Ezetimiba Alter
- Romania · Co-Atoris, Coleatez
- Sweden · Atozet, Ezetimib/Atorvastatin Krka
- Slovenia · Aterezim, Ezetimib/Atorvastatin Alkaloid-Int
- Slovakia · Atoritimb, Atorvastatín/Ezetimib Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dcca7526-0a33-4012-b0f4-e3c64cf36071 GET /v1/drugs/dcca7526-0a33-4012-b0f4-e3c64cf36071?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62476935",
"date_amm": "2024-01-15",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "ÉZÉTIMIBE + ATORVASTATINE CALCIQUE TRIHYDRATÉE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about ézétimibe + atorvastatine calcique trihydratée.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.